These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6337426)
21. Efficacy of dual antiplatelet therapy in cerebrovascular disease as demonstrated by a decline in microembolic signals. A report of eight cases. Esagunde RU; Wong KS; Lee MP; Gan HY; Wong MC; Chang HM; Chen CL Cerebrovasc Dis; 2006; 21(4):242-6. PubMed ID: 16446537 [TBL] [Abstract][Full Text] [Related]
22. Controlled trial of aspirin in cerebral ischemia. Part II: surgical group. Fields WS; Lemak NA; Frankowski RF; Hardy RJ Stroke; 1978; 9(4):309-19. PubMed ID: 354098 [TBL] [Abstract][Full Text] [Related]
24. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. Canadian Cooperative Study Group N Engl J Med; 1978 Jul; 299(2):53-9. PubMed ID: 351394 [TBL] [Abstract][Full Text] [Related]
25. Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Koudstaal PJ; Algra A; Pop GA; Kappelle LJ; van Latum JC; van Gijn J Lancet; 1992 Sep; 340(8820):630-3. PubMed ID: 1355211 [TBL] [Abstract][Full Text] [Related]
26. Transient ischemic attack: an early warning system for stroke? Greenhouse AH Geriatrics; 1973 Sep; 28(9):134-9. PubMed ID: 4725689 [No Abstract] [Full Text] [Related]
28. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. Tran H; Anand SS JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585 [TBL] [Abstract][Full Text] [Related]
29. Aspirin for prevention of stroke: a review. Fields WS Am J Med; 1983 Jun; 74(6A):61-5. PubMed ID: 6344627 [TBL] [Abstract][Full Text] [Related]
30. A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Candelise L; Landi G; Perrone P; Bracchi M; Brambilla G Stroke; 1982; 13(2):175-9. PubMed ID: 7039004 [TBL] [Abstract][Full Text] [Related]
31. The European Stroke Prevention Study: results according to sex. Sivenius J; Laakso M; Penttilä IM; Smets P; Lowenthal A; Riekkinen PJ Neurology; 1991 Aug; 41(8):1189-92. PubMed ID: 1866002 [TBL] [Abstract][Full Text] [Related]
32. Trials of trials in acute ischemic stroke. The Humana Lecture. Adams HP Stroke; 1993 Sep; 24(9):1410-5. PubMed ID: 8362441 [No Abstract] [Full Text] [Related]
33. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. ; van Gijn J; Algra A; Kappelle J; Koudstaal PJ; van Latum A N Engl J Med; 1991 Oct; 325(18):1261-6. PubMed ID: 1922220 [TBL] [Abstract][Full Text] [Related]
35. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM; Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653 [TBL] [Abstract][Full Text] [Related]
36. Aspirin for the limping brain. Hass WK Stroke; 1977; 8(3):299-301. PubMed ID: 324035 [No Abstract] [Full Text] [Related]